(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TRIMT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

TRIMT

ST13

US500000079333791

Class

1, 5, 35, 42

Filing

79333791

Registration

7383132

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

06/25/2026

Trademark type

Combined

Nice classes

1, 5, 35, 42

Filing date

01/06/2022

Registration date

05/14/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/14/2024

Last transaction

06/25/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

27

Owner location

DE

Examiner

VAGHANI, MAYUR C

Law office

N60

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized word "TRIMT" in grey with a nine-sided polygon to the left in grey. The color white represents background and is not part of the mark.

Holders and representatives

Holders

TRIMT GmbH

Representatives

Michael E. Robinson ROBINSON IP LAW, PLLC

Technical classification

Nice Classes

Class 1Class 5Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical preparations for use in the manufacture of pharmaceuticals; diagnostic preparations for scientific purposes; radioactive materials in the nature of radiolabelled small and non-small molecules for scientific purposes

Class 5

Chemical preparations for pharmaceutical purposesfor treatments of oncological diseasesautoimmune diseases and immunodeficiency diseases and for the purpose of radioligand therapy of avb6 integrin receptor expressing tumors by labelling with radionuclides; chemical preparations for medical purposesfor treatments of oncological diseasesautoimmune diseases and immunodeficiency diseases and for the purpose of radioligand therapy of avb6 integrin receptor expressing tumors by labelling with radionuclides; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; agents for nuclear medicine in the nature of radioactive substances for use in nuclear medicine; radioactive substances for medical purposes

Class 35

Retail and wholesale store services online and through local distributors featuring pharmaceutical and medical products

Class 42

Pharmaceutical research and development for the pharmaceutical industry; consultancy relating to pharmaceutical research and development

Publications

History of USPTO decisions and trademark events.

36 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/25/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/23/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/06/2024

FIMP

FINAL DISPOSITION PROCESSED

11/06/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/14/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/14/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

05/14/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/04/2024

PUBO

PUBLISHED FOR OPPOSITION

02/27/2024

GPNX

NOTIFICATION PROCESSED BY IB

02/26/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/07/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/07/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/07/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/07/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/18/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/03/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/02/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

01/02/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

08/06/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/19/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

07/19/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

07/12/2023

GNFR

FINAL REFUSAL E-MAILED

07/12/2023

CNFR

FINAL REFUSAL WRITTEN

07/12/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/20/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/19/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/19/2023

RFNT

REFUSAL PROCESSED BY IB

01/25/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/29/2022

RFRR

REFUSAL PROCESSED BY MPU

12/29/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/14/2022

CNRT

NON-FINAL ACTION WRITTEN

10/13/2022

DOCK

ASSIGNED TO EXAMINER

10/13/2022

MAFR

APPLICATION FILING RECEIPT MAILED

02/22/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/18/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/17/2022

Continuous trademark protection

Get notified about every new filing that threatens TRIMT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.